Acticor Biotech’s IPO

McDermott has advised Acticor Biotech on the offering.Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies, executed…

This content is for Standard 1 Year members only.
Login Join Now
Naoual Sadouqi

Author: Naoual Sadouqi

This content is for Standard 1 Year members only.
Login Join Now